P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 214 000 KRW -2.28%
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaResearch Co Ltd
Cash from Operating Activities Peer Comparison

Comparables:
068270
302440
H
145020
196170
A
298380

Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Cash from Operating Activities
â‚©104.3B
CAGR 3-Years
31%
CAGR 5-Years
51%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Cash from Operating Activities
â‚©432.3B
CAGR 3-Years
-7%
CAGR 5-Years
2%
CAGR 10-Years
10%
SK Bioscience Co Ltd
KRX:302440
Cash from Operating Activities
â‚©29.3B
CAGR 3-Years
-38%
CAGR 5-Years
15%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Cash from Operating Activities
â‚©117.7B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Cash from Operating Activities
â‚©16.1B
CAGR 3-Years
159%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
A
ABL Bio Inc
KOSDAQ:298380
Cash from Operating Activities
-â‚©78.9B
CAGR 3-Years
-23%
CAGR 5-Years
-53%
CAGR 10-Years
N/A

See Also

What is PharmaResearch Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
104.3B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Cash from Operating Activities amounts to 104.3B KRW.

What is PharmaResearch Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
51%

Over the last year, the Cash from Operating Activities growth was 107%. The average annual Cash from Operating Activities growth rates for PharmaResearch Co Ltd have been 31% over the past three years , 51% over the past five years .

Back to Top